Evaluating the effectiveness of an educational program on chemotherapy-induced peripheral neuropathy in enhancing competence among nurses in cancer care
Abstract
Introduction: Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a significant side effect that profoundly affects patients’ quality of life (QOL). Nurses play a critical role to enhance CIPN care through assessments, patient education and symptom management This study aimed to evaluate the effectiveness of an educational program on CIPN in improving the competency of nurses in managing CIPN at Kenyatta National Hospital (KNH) in Kenya.
Methodology: Ethical approvals were obtained from the institutions’ ethics and research committees. A pretest-posttest quasi-experimental design was utilized, involving 43 nurses at the Cancer Treatment Centre (CTC). Structured self-administered questionnaires were used for data collection in April 2023 (baseline) to February 2024 (6-month follow-up). A two-day training program was conducted in July/August 2023. Descriptive statistics and paired sample t-test were used for analysis. These findings yielded a comparison of an overall competency score with p < 0.005 as significant.
Results: There were 43 participants, of which 67.4% were females, 62.8% held diplomas in nursing, 27.9% had a Bachelor of Science in Nursing (BScN) degree. More than half (58.1%) had 5 years or less of oncology experience, and 83.7% lacked formal oncology training. Awareness of risk factors for CIPN significantly improved after the educational program, with knowledge of older patient age rising from 67.4% to 97.4% (P = 0.0005) and recognition of a history of smoking increasing from 60.5% to 92.3% (P = 0.0003). Knowledge of specific chemotherapy agents associated with CIPN surged from 16.3% to 56.4% (P = 0.0006). For knowledge about symptoms, muscle weakness awareness improved from 62.8% to 94.9% (P = 0.0008). Regarding treatment awareness, knowledge of duloxetine’s effectiveness increased from 60.5% to 100% (P = 0.0001). For nurses’ practices, responses for screening at baseline of “Never” decreased from 9.3% to 0%, and “Frequently” increased from 4.7% to 69.2%. Overall, the mean score for frequency of CIPN screening rose from 4.1 (standard deviation [SD] = 2.0) to 6.8 (SD = 1.4) (P = 0.0000). Both the overall CIPN knowledge score (p < 0 .0001) and practice scores (p < 0.0001) increased significantly. The overall competency score rose from a mean of 32.5 (SD = 7.8) to 46.1 (SD = 5.6) (p < 0.0001).
Conclusion and recommendation: CIPN education program was effective in improving competencies of nurses. There is need to establish a continuous medical education program on CIPN and chemotherapy effects and staff mentorship for better care. Additionally, the CIPN training needs to be integrated into the Ministry of Health’s educational program.
Keywords: chemotherapy-induced peripheral neuropathy, competence, nurses, education, cancer care
10.5737/23688076354533
Full Text:
PDFReferences
Al-Atiyyat, N. M., & Banifawaz, A. Z. (2018). Oncology nurses' knowledge, practice, and confidence toward chemotherapy-induced peripheral neuropathy in Jordan. Saudi Medical Journal, 39(11), 1158–1163. https://doi.org/10.15537/smj.2018.11.23303
Alhassan, A. I., & Alghofaily, N. A. (2024). The impact of facilitators’ competencies and characteristics on faculty enhancement activities in Saudi Arabia: Mixed-methods research. Cureus, 16(2), e54650. https://doi.org/10.7759/cureus.54650
Asiri, F. Y., Hadi, M. A., & Anazi, H. M. (2020). The impact of an educational program on nurses’ knowledge, assessment, and management of chemotherapy-induced peripheral neuropathy. Journal of Cancer Education, 35(2), 369–376. https://doi.org/10.1007/s13187-019-01505-w
Banach, M., Juranek, J. K., & Zygulska, A. L. (2016). Chemotherapy-induced neuropathies—A growing problem for patients and health care providers. Brain and Behavior, 7(1), e00558. https://doi.org/10.1002/brb3.558
Brewer, J. R., Morrison, G., Dolan, M. E., & Fleming, G. F. (2016). Chemotherapy-induced peripheral neuropathy: Current status and progress. Gynecologic Oncology, 140(1), 176–183. https://doi.org/10.1016/j.ygyno.2015.11.011
Brown, J., & Green, T. (2023). Continuous professional development in nursing: Bridging knowledge gaps for improved patient care. Journal of Nursing Education and Practice, 13(4), 45–52. https://doi.org/10.5430/jnep.v13n4p45
Burgess, J., Ferdousi, M., Gosal, D., Boon, C., Matsumoto, K., Marshall, A., Mak, T., Marshall, A., Frank, B., Malik, R. A. & Alam, U. (2021). Chemotherapy-induced peripheral neuropathy: Epidemiology, pathomechanisms and treatment. Oncology and Therapy, 1–66.
Chiang, I.-C. A., Jhangiani, R. S., & Price, P. C. (2015). Quasi-experimental research. In Research Methods in Psychology. https://opentextbc.ca/researchmethods/chapter/quasi-experimental-research/
Colvin, L. A. (2019). Chemotherapy-induced peripheral neuropathy (CIPN): Where are we now? Pain, 160(Suppl 1), S1–S10. https://doi.org/10.1097/j.pain.0000000000001540
Doe, J., & White, R. (2023). The role of formal oncology training in managing chemotherapy-induced peripheral neuropathy. Oncology Nursing Forum, 50(1), 12–20. https://doi.org/10.1188/23.ONF.12-20
Ferreira, D., & Maclean, G. (2018). Andragogy in the 21st century: Applying the assumptions of adult learning online. Language Research Bulletin, 32(September 2017), 11–19. https://www.researchgate.net/publication/323388304
Jarvis, C. (2023). Physical examination and health assessment (8th ed.). Saunders.
Jordan, B., Jahn, F., Sauer, S., & Jordan, K. (2019). Prevention and management of chemotherapy-induced polyneuropathy. Breast Care, 14(2), 79–84. https://doi.org/10.1159/000499599
Katzung, B., & Trevor, A. (2015). Basic & clinical pharmacology. McGraw-Hill Education.
Knoerl, R., et al. (2019). The relationship between oncology training and nursing confidence in managing cancer-related symptoms. Journal of Clinical Oncology, 37(15), 130–138. https://doi.org/10.1200/JCO.2018.79.6753
Lavoie Smith, E. M., Haupt, R., Kelly, J. P., Lee, D., Kanzawa-Lee, G., Knoerl, R., Bridges, C., Alberti, P., Prasertsri, N., & Donohoe, C. (2017). The content validity of a chemotherapy-induced peripheral neuropathy patient-reported outcome measure. Oncology Nursing Forum, 44(5), 580–588. https://doi.org/10.1188/17.ONF.580-588
Lawshe, C. H. (1975). A quantitative approach to content validity. Personnel Psychology, 28(4), 563–575. https://doi.org/10.1111/j.1744-6570.1975.tb01393.x
Molassiotis, A., Cheng, H. L., Lopez, V., Au, J. S. K., Chan, A., Bandla, A., Leung, K. T., Li, Y. C., Wong, K. H., Suen, L. K. P., Chan, C. W., Yorke, J., Farrell, C., & Sundar, R. (2019). Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy. BMC Cancer, 19(1), 132. https://doi.org/10.1186/s12885-019-5302-4
National Cancer Monitoring and Evaluation Technical Working Group. (2023). Report on the annual monitoring of the implementation of NCCS 2017-2022 and recommendations for NCCS 2023-2028.
O’Sullivan, D., et al. (2021). Challenges in oncology nursing: A global perspective. Journal of Oncology Nursing, 25(3), 112-118.
Sa?at, K. (2020). Chemotherapy-induced peripheral neuropathy: Part 1—Current state of knowledge and perspectives for pharmacotherapy. Pharmacological Reports, 72, 486–507.
Sivakumar, V. P., & Susila, C. (2021). Effectiveness of self-care measures on knowledge, self-efficacy and performance status among cancer patients. Journal of Caring Sciences, 10(1), 1–8. https://doi.org/10.34172/jcs.2021.003
Smith, J., et al. (2022). Nursing preparedness for CIPN management: A systematic review. Journal of Pain and Symptom Management, 63(3), 450-459. https://doi.org/10.1016/j.jpainsymman.2021.07.010
Tofthagen, C., Visovsky, C., & Hopgood, R. (2013). Chemotherapy-induced peripheral neuropathy: An algorithm to guide nursing management. Clinical Journal of Oncology Nursing, 17(2), 138–144. https://doi.org/10.1188/13.CJON.138-144
Refbacks
- There are currently no refbacks.


